Journal of Hereditary Tumors
Online ISSN : 2435-6808
Clinical Experience
Establishing the foundation of a hereditary cancer genomics program and our original ingenuity
Kouji OhtaTomoko ItohIkue Hata
Author information
JOURNAL OPEN ACCESS

2022 Volume 22 Issue 1 Pages 30-34

Details
Abstract

 Since the treatment of hereditary breast and ovarian cancer and the cancer genome medical system were approved in Japan, cancer genomics has become part of the clinical setting. However, as Fukui Prefectural Hospital prioritizes public health medicine, it has not been able to spare enough human resources to begin a cancer genomics program until recently. To solve this problem, the genomic doctor and nurse and other member of staff have been elected from each department related to cancer genomics. Nurses and medical record managers play a more important role than initially expected. The implementation of our system offers insights that would be helpful to other hospitals. Herein, we report details of the system of genomic doctors, our history up to launching the department, and several problems we encountered.

Content from these authors
© 2022 The Japanese Society for Hereditary Tumors
Previous article Next article
feedback
Top